These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6004069)

  • 1. [On the medical treatment of metastases of hypernephroid cancer of the kidneys].
    Evseenko LS; Orlova RS; Barsel' VA; Disvetova VV
    Vopr Onkol; 1966; 12(9):53-5. PubMed ID: 6004069
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of advanced adenocarcinoma of the kidney with ICRF-187: a Southeastern Cancer Study Group Trial.
    Brubaker LH; Vogel CL; Einhorn LH; Birch R
    Cancer Treat Rep; 1986 Jul; 70(7):915-6. PubMed ID: 3087618
    [No Abstract]   [Full Text] [Related]  

  • 3. [Results of the use of thiodipin in chronic lympholeukosis].
    Mokeeva RA; Zhuravlev VS; Rybakova ME
    Sov Med; 1968 Apr; 31(4):99-102. PubMed ID: 5669785
    [No Abstract]   [Full Text] [Related]  

  • 4. [The treatment of metastasizing hypernephroid (renal cell) carcinoma with medroxyprogesterone acetate (Clinovir) (author's transl].
    von Lieven H; Hahn D
    MMW Munch Med Wochenschr; 1977 Aug; 119(34):1089-92. PubMed ID: 408657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The sensitivity of human kidney cancer in cultures to antitumor preparations].
    Terent'eva TG; Fomina IP; Navashin SM; Martochkina GA
    Vopr Onkol; 1971; 17(7):67-70. PubMed ID: 5002944
    [No Abstract]   [Full Text] [Related]  

  • 6. Piperazinedione in metastatic renal carcinoma.
    Pasmantier MW; Coleman M; Kennedy BJ; Eagan R; Carolla R; Weiss R; Leone L; Silver RT
    Cancer Treat Rep; 1977 Dec; 61(9):1731-2. PubMed ID: 340039
    [No Abstract]   [Full Text] [Related]  

  • 7. Single-agent therapy for renal cell carcinoma: CCNU, vinblastine, thioTEPA, or bleomycin.
    Hahn DM; Schimpff SC; Ruckdeschel JC; Wiernik PH
    Cancer Treat Rep; 1977 Nov; 61(8):1585-7. PubMed ID: 72603
    [No Abstract]   [Full Text] [Related]  

  • 8. [New aspects in the treatment of the hypernephroid carcinoma of the kidneys (author's transl)].
    Bruhl P; Scheef W; Albert H; Bucheler E
    J Urol Nephrol (Paris); 1976 Jun; 82(6):417-27. PubMed ID: 823343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Modern drugs for the treatment of cancer].
    Chernov VA; Safonova TS
    Khirurgiia (Mosk); 1966 Apr; 42(4):142-51. PubMed ID: 4967881
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of metastatic renal cell carcinoma: review of experience and world literature.
    Luderer RC; Opipari MI; Perrotta AL
    J Am Osteopath Assoc; 1978 Apr; 77(8):590-603. PubMed ID: 649445
    [No Abstract]   [Full Text] [Related]  

  • 11. [Results of determining the sensitivity of hypernephroid cancer to cytostatic agents in vitro and clinically].
    Terent'eva TG; Matveev BP; Martochkina GA; Marinbakh EB
    Antibiotiki; 1977 Jul; 22(7):648-52. PubMed ID: 329755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Protracted regression of lung metastases in the course of kidney cancer surgery and after cytostatic treatment].
    Bross W; Bross T; Kaniowski T; Kozuszek W; Olejak B; Masiak M; Krupacz R
    Wiad Lek; 1970 Sep; 23(18):1587-9. PubMed ID: 5471191
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of metastatic renal cancer with ifosfamide and mesnum with and without irradiation.
    Fosså SD; Talle K
    Cancer Treat Rep; 1980; 64(10-11):1103-8. PubMed ID: 6780190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Course of pulmonary metastases from kidney cancer treated by chemotherapy].
    Thomas JP; Timbal Y; Garreta L; Debonnière C; Serrault M
    J Urol Nephrol (Paris); 1974; 80(1):136-40. PubMed ID: 4841732
    [No Abstract]   [Full Text] [Related]  

  • 15. [A new method for administering cytostatics. Preliminary evaluation in 7 cases of adenocarcinoma of the kidney].
    Escudero Barrilero A; Mateos Torres A; Maganto Pavón E; Mayayo Dehesa R; Allona Almagro A; Zubicoa Ezpeleta S; García González R
    Arch Esp Urol; 1984 Dec; 37 Suppl 1():593-605. PubMed ID: 6543489
    [No Abstract]   [Full Text] [Related]  

  • 16. Phase II trial of spirogermanium in advanced renal cell carcinoma: a Cancer and Leukemia Group B study.
    Schulman P; Davis RB; Rafla S; Green M; Henderson E
    Cancer Treat Rep; 1984 Oct; 68(10):1305-6. PubMed ID: 6525606
    [No Abstract]   [Full Text] [Related]  

  • 17. [Current treatment of hypernephroid carcinoma].
    Wasmund HG; Schneider HJ
    Z Arztl Fortbild (Jena); 1970 Mar; 64(5):222-4. PubMed ID: 4107115
    [No Abstract]   [Full Text] [Related]  

  • 18. Phase II trial of diaziquone in advanced renal adenocarcinoma.
    Hansen M; Gallmeier WM; Vermorken J; Holdener E; Hansen HH; Renard J; Rozencweig M
    Cancer Treat Rep; 1984; 68(7-8):1055-6. PubMed ID: 6744342
    [No Abstract]   [Full Text] [Related]  

  • 19. [Results of drug therapy of metastasis of carcinoma of the kidney].
    Barsel' VA; Khaimchaev IaS
    Urol Nefrol (Mosk); 1977; (1):41-3. PubMed ID: 841765
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical use of prospidine].
    Barsel' VA; Disvetova VV; Evseenko LS; Orlova RS; Tverdynin MS
    Vopr Onkol; 1970; 16(8):36-41. PubMed ID: 5501882
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.